Clinical trials
Completed Phase 3 Wounds and Injuries trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 9 |
| 2011 | 4 |
| 2012 | 7 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 5 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Birken AG | 2 |
| Olympus Biotech Corporation | 2 |
| University of Monastir | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Associazione Infermieristica per lo studio delle Lesioni Cutanee | 1 |
| Australian and New Zealand Intensive Care Research Centre | 1 |
| BHR Pharma, LLC | 1 |
| Brigham and Women's Hospital | 1 |
| Cephalon | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wounds and Injuries | 58 |
| Shock, Hemorrhagic | 5 |
| Acute Pain | 4 |
| Brain Injuries, Traumatic | 4 |
| Hemostatic Disorders | 4 |
| Pain | 4 |
| Stress Disorders, Post-Traumatic | 4 |
| Hemorrhage | 3 |
| Osteoarthritis | 3 |
| Shock | 3 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.